Knight Therapeutics's market cap is currently $395.05M. The company's EPS TTM is $-0.223; its P/E ratio is ―; Knight Therapeutics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	C$ 328.20M	C$ 293.56M	C$ 243.48M	C$ 199.52M	C$ 47.46M
Gross Profit	C$ 152.65M	C$ 138.06M	C$ 115.41M	C$ 81.69M	C$ 26.92M
Operating Income	C$ -2.89M	C$ -2.40M	C$ -5.32M	C$ -3.44M	C$ 13.99M
EBITDA	C$ 40.90M	C$ 25.26M	C$ 42.59M	C$ 67.56M	C$ 27.16M
Net Income	C$ -16.84M	C$ -29.89M	C$ 15.68M	C$ 31.76M	C$ 14.52M
Balance Sheet
Cash & Short-Term Investments	C$ 154.42M	C$ 191.22M	C$ 162.99M	C$ 411.34M	C$ 430.62M
Total Assets	C$ 945.49M	C$ 1.05B	C$ 991.89M	C$ 1.04B	C$ 1.31B
Total Debt	C$ 69.09M	C$ 77.70M	C$ 40.96M	C$ 56.19M	C$ 62.18M
Net Debt	C$ 10.33M	C$ 6.02M	C$ -45.01M	C$ -173.40M	C$ -107.09M
Total Liabilities	C$ 198.62M	C$ 228.98M	C$ 149.87M	C$ 153.44M	C$ 390.20M
Stockholders' Equity	C$ 746.87M	C$ 825.86M	C$ 842.02M	C$ 886.24M	C$ 810.73M
Cash Flow
Free Cash Flow	C$ 25.98M	C$ 14.66M	C$ -179.56M	C$ -32.87M	C$ 1.65M
Operating Cash Flow	C$ 35.94M	C$ 40.48M	C$ 44.62M	C$ -12.21M	C$ 4.60M
Investing Cash Flow	C$ 29.34M	C$ -63.08M	C$ -105.28M	C$ 101.35M	C$ -11.86M
Financing Cash Flow	C$ -81.00M	C$ 1.76M	C$ -78.31M	C$ -29.23M	C$ -62.80M

Currency in CAD

Knight Therapeutics Earnings and Revenue History

Income Statement >

Knight Therapeutics Debt to Assets

Balance Sheet >

Knight Therapeutics Cash Flow

Cash Flow >

Knight Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing